Search research articles
Contact Us
Filters
Showing results (11-20 of 115) with videos related to
Page
of 12
Sort By:
Infection
|
April 8, 2024
The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study
Anne-Eva Post, Erik Bathoorn, Douwe F Postma, et al.
The European Respiratory Journal
|
September 14, 2019
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands
Fajri Gafar, Natasha Van't Boveneind-Vrubleuskaya, Onno W Akkerman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 31, 2020
Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?
Jan-Willem C Alffenaar, Onno W Akkerman, Hannah Yejin Kim, et al.
Antimicrobial Resistance and Infection Control
|
July 25, 2019
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015
Ivan S Pradipta, Natasha Van't Boveneind-Vrubleuskaya, Onno W Akkerman, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2013
Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response
Onno W Akkerman, Richard van Altena, Mathieu S Bolhuis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment
Marieke G G Sturkenboom, Noviana Simbar, Onno W Akkerman, et al.
The Journal of Infectious Diseases
|
March 6, 2019
Tuberculosis-Related Malnutrition: Public Health Implications
Lies Ter Beek, Jan-Willem C Alffenaar, Mathieu S Bolhuis, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 25, 2023
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
Lina Keutzer, Laurynas Mockeliunas, Marieke G G Sturkenboom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 14, 2023
Update of drug-resistant tuberculosis treatment guidelines: A turning point
Elisa Vanino, Bianca Granozzi, Onno W Akkerman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 17, 2025
Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment
A Mireille A Wessels, Femke A Elzinga, Gerard H Koppelman, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 115) with videos related to
Sort By:
Page
of 12
Infection
|
April 8, 2024
The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study
Anne-Eva Post, Erik Bathoorn, Douwe F Postma, et al.
The European Respiratory Journal
|
September 14, 2019
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands
Fajri Gafar, Natasha Van't Boveneind-Vrubleuskaya, Onno W Akkerman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 31, 2020
Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?
Jan-Willem C Alffenaar, Onno W Akkerman, Hannah Yejin Kim, et al.
Antimicrobial Resistance and Infection Control
|
July 25, 2019
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015
Ivan S Pradipta, Natasha Van't Boveneind-Vrubleuskaya, Onno W Akkerman, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2013
Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response
Onno W Akkerman, Richard van Altena, Mathieu S Bolhuis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment
Marieke G G Sturkenboom, Noviana Simbar, Onno W Akkerman, et al.
The Journal of Infectious Diseases
|
March 6, 2019
Tuberculosis-Related Malnutrition: Public Health Implications
Lies Ter Beek, Jan-Willem C Alffenaar, Mathieu S Bolhuis, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 25, 2023
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
Lina Keutzer, Laurynas Mockeliunas, Marieke G G Sturkenboom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 14, 2023
Update of drug-resistant tuberculosis treatment guidelines: A turning point
Elisa Vanino, Bianca Granozzi, Onno W Akkerman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 17, 2025
Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment
A Mireille A Wessels, Femke A Elzinga, Gerard H Koppelman, et al.
Page
of 12